Kenneth Poemoceah
Family Medicine · Gravette, ARNPI 1881652592
Payments from drug & device makers
Across 120 payments — averaging $30.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$933
- AstraZeneca$708
- AbbVie$419
- Astellas Pharma US Inc$198
- GSK$197
- BETA Bionics, Inc.$152
- plus $1K from 23 others
What the payments were for
- Food & beverage$3,41894%
- Education$2346%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 12 | $933 |
| AstraZeneca | 11 | $708 |
| AbbVie(2 entities) | 22 | $419 |
| Astellas Pharma US Inc | 2 | $198 |
| GSK | 15 | $197 |
| BETA Bionics, Inc. | 2 | $152 |
| Gilead | 8 | $152 |
| Abbott | 6 | $107 |
| Amgen | 4 | $89 |
| Pfizer | 4 | $79 |
| Teva Pharmaceuticals USA, Inc. | 4 | $78 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $57 |
| Indivior Inc. | 3 | $52 |
| Exact Sciences | 3 | $44 |
| Daiichi Sankyo Inc. | 2 | $44 |
| Lilly USA, LLC | 3 | $43 |
| Dexcom, Inc. | 2 | $38 |
| Biohaven Pharmaceuticals, Inc. | 2 | $32 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| Vertex | 1 | $28 |
| Avanir Pharmaceuticals, Inc. | 2 | $27 |
| Organon | 1 | $27 |
| Nestle Healthcare Nutrition Inc. | 1 | $23 |
| Viatris Specialty LLC | 1 | $21 |
| Johnson & Johnson | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
| Electromed, Inc. | 1 | $15 |
| Bayer | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iLet Bionic Pancreas$386
- Ozempic$367
- FARXIGA$360
- RYBELSUS$250
- AIRSUPRA$125
- TRELEGY ELLIPTA$124
How this compares
$3,652 in reported general payments places this provider in the 80th percentile of 1,347 family medicine providers in Arkansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 125 | $125,253 |
| XareltoRivaroxaban | 69 | $38,981 |
| Tresiba Flextouch U-200Insulin Degludec | 26 | $20,336 |
| Breo ElliptaFluticasone/Vilanterol | 45 | $17,773 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 25 | $17,206 |
| EntrestoSacubitril/Valsartan | 14 | $16,942 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 96 | $12,015 |
| MounjaroTirzepatide | 11 | $11,663 |
| EliquisApixaban | 19 | $11,140 |
| Repatha SureclickEvolocumab | 14 | $7,594 |
| JardianceEmpagliflozin | 11 | $7,142 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 11 | $6,991 |
| JanuviaSitagliptin Phosphate | 12 | $6,764 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 243 | $6,368 |
| OxycontinOxycodone Hcl | 12 | $5,681 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $933 | $125,253125 claims |
| GSKBreo Ellipta, Trelegy Ellipta, Anoro Ellipta | $197 | $40,58482 claims |
| Johnson & JohnsonXarelto | $18 | $38,98169 claims |
| Lilly USA, LLCMounjaro | $43 | $11,66311 claims |
| PfizerEliquis | $79 | $11,14019 claims |
| AstraZenecaBreztri Aerosphere | $708 | $6,99111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,347 family medicine providers in Arkansas.
Other family medicine in Gravette
- George KonisLittle Rock$26.6M
- Kevin RobertsLittle Rock$2.5M
- Derek LewisLittle Rock$1.7M
- Jodi SansonHot Springs$1.7M
- Senthil RaghavanLittle Rock$496K
- Broderick EatonWynne$442K
- Landon HumphreyConway$417K
- Vonda HouchinHarrisburg$206K
- Glenn GibbonsFort Smith$179K
- Christopher BrownJonesboro$160K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.